Hypothetically, our findings may be explained by immunomodulatory changes related to pregnancy, for example a decrease of anti-inflammatory cytokines [20] and regulatory CD4+ T cells [21] postpartum, which could drive the progression of ACPA-negative RA in younger women, especially close to delivery. Here, CD4 is linked to rheumatoid arthritis.